DETERMINATION OF THE ANTI-FACTOR Xa ACTIVITY OF THE SYNTHETIC PENTASACCHARIDE SR 90107A/ORG 31540 AND OF TWO STRUCTURAL ANALOGUES

By Lormeau J.C.   Herault J.P.   Gaich C.   Barzu T.   van Dinther T.G.   Visser A.   Herbert J.M.  

Thrombosis Research, Vol. 85, Iss. 1, 1997-01 ,pp. : 67-75

Elsevier

Access to resources Recommend Favorite

BIOCHEMICAL AND PHARMACOLOGIC RATIONALE FOR THE DEVELOPMENT OF A SYNTHETIC HEPARIN PENTASACCHARIDE

By Walenga J.M.   Jeske W.P.   Bara L.   Samama M.M.   Fareed J.  

Thrombosis Research, Vol. 86, Iss. 1, 1997-04 ,pp. : 1-36

Elsevier

Access to resources Recommend Favorite

Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux)

By Samama M.-M.   Gerotziafas G.T.  

Thrombosis Research, Vol. 109, Iss. 1, 2003-01 ,pp. : 1-11

Elsevier

Access to resources Recommend Favorite

Heparinase I acts on a synthetic heparin pentasaccharide corresponding to the antithrombin III binding site

By Yu G.   LeBrun L.   Gunay N.S.   Hoppensteadt D.   Walenga J.M.   Fareed J.   Linhardt R.J.  

Thrombosis Research, Vol. 100, Iss. 6, 2000-12 ,pp. : 549-556

Elsevier

Access to resources Recommend Favorite

Atorvastatin and the plasma activities of lipoprotein lipase, hepatic lipase and lecithin:cholesterol acyltransferase in patients with mixed hyperlipidemia

By Heller F.R.   Descamps O.S.   Hondekijn J.C.   Desager J.P.  

European Journal of Internal Medicine, Vol. 11, Iss. 1, 2000-02 ,pp. : 33-38

Elsevier

Access to resources Recommend Favorite